Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).

Willenbacher, W, Thangavadivel, S, Greil, R, Willenbacher, E, Weger, R, Manzl, C, Jöhrer, K, Brunner, A.